Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Boers, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 103 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Verhoeven, AC; Boers, M; Koppele, JMT; van der Laan, WH; Markusse, HM; Geusens, P; van der Linden, S
      Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone

      RHEUMATOLOGY
    2. Vignon, E; Garnero, P; Delmas, P; Avouac, B; Bettica, P; Boers, M; Ehrich, E; MacKillop, N; Rovati, L; Serni, U; Spector, T; Reginster, JY
      Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers

      OSTEOARTHRITIS AND CARTILAGE
    3. Verhagen, AP; de Vet, HCW; de Bie, RA; Boers, M; van den Brandt, PA
      The art of quality assessment of RCTs included in systematic reviews

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    4. Boers, M
      Rheumatoid arthritis - Treatment of early disease

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    5. Verhoeven, AC; Boers, M; Koppele, JMT; van der Laan, WH; de Roos, J; van der Linden, S
      Reliability of spot samples for assessment of urinary excretion of pyridinoline in patients with rheumatoid arthritis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    6. Boers, M
      Methodology of combination trials

      SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    7. Boers, M
      Bias in its coat of many colors

      JOURNAL OF RHEUMATOLOGY
    8. Welch, V; Singh, G; Strand, V; Fries, J; Boers, M; Ramey, D; Day, RO; Brooks, P; Tugwell, P; Clinch, J; Kristjansson, B
      Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index

      JOURNAL OF RHEUMATOLOGY
    9. Verburg, RJ; Sont, JK; Vlieland, TPMV; Landewe, RB; Boers, M; Kievit, J; van Laar, JM
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis

      JOURNAL OF RHEUMATOLOGY
    10. Strand, V; Lassere, M; van der Heijde, D; Johnson, K; Boers, M
      Recent rheumatoid arthritis clinical trials using radiographic endpoints -Updated research agenda

      JOURNAL OF RHEUMATOLOGY
    11. Lassere, MND; van der Heijde, D; Johnson, KR; Boers, M; Edmonds, J
      Reliability of measures of disease activity and disease damage in rheumatoid arthritis: Implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials

      JOURNAL OF RHEUMATOLOGY
    12. Bruynesteyn, K; van der Heijde, D; Boers, M; Lassere, M; Boonen, A; Edmonds, J; Houben, H; Paulus, H; Peloso, P; Saudan, A; van der Linden, S
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: Preliminary results of a validation study with clinical experts

      JOURNAL OF RHEUMATOLOGY
    13. Lassere, MND; van der Heijde, D; Johnson, K; Bruynesteyn, K; Molenaar, E; Boonen, A; Verhoeven, A; Emery, P; Boers, M
      Robustness and generalizability of smallest detectable difference in radiological progression

      JOURNAL OF RHEUMATOLOGY
    14. van der Heijde, D; Lassere, M; Edmonds, J; Kirwan, J; Strand, V; Boers, M
      Minimal clinically important difference in plain films in RA: Group discussions, conclusions, and recommendations

      JOURNAL OF RHEUMATOLOGY
    15. Gabriel, S; Drummond, M; Coyle, D; Suarez-Almazor, ME; Ruff, B; Guillemin, F; Bombardier, C; Boers, M; Maetzel, A; Ruof, J; Cranney, A; Marentette, M; Tugwell, P
      OMERACT 5 Economics Working Group: Summary, recommendations, and research agenda

      JOURNAL OF RHEUMATOLOGY
    16. Tugwell, P; Boers, M; Brooks, PM; Simon, L; Strand, CV
      OMERACT 5. International Consensus Conference on Outcome Measures in Rheumatology - Introduction

      JOURNAL OF RHEUMATOLOGY
    17. Beaton, DE; Bombardier, C; Katz, JN; Wright, JG; Wells, G; Boers, M; Strand, V; Shea, B
      Looking for important change/differences in studies of responsiveness

      JOURNAL OF RHEUMATOLOGY
    18. Wells, G; Beaton, D; Shea, B; Boers, M; Simon, L; Strand, V; Brooks, P; Tugwell, P
      Minimal clinically important differences: Review of methods

      JOURNAL OF RHEUMATOLOGY
    19. Wells, G; Anderson, J; Beaton, D; Bellamy, N; Boers, M; Bombardier, C; Breedveld, F; Carr, A; Cranney, A; Dougados, M; Felson, D; Kirwan, J; Schiff, M; Shea, B; Simon, L; Smolen, J; Strand, V; Tugwell, P; van Riel, P; Welch, VA
      Minimal clinically important difference module: Summary, recommendations, and research agenda

      JOURNAL OF RHEUMATOLOGY
    20. van Tinteren, H; Hoekstra, OS; Smit, EF; Verboom, P; Boers, M
      Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography

      CONTROLLED CLINICAL TRIALS
    21. Moll, AC; Imhof, SM; Schouten-VanMeeteren, YN; Kuik, DJ; Hofman, P; Boers, M
      Second primary tumors in hereditary retinoblastoma: A register-based study, 1945-1997 - Is there an age effect on radiation-related risk?

      OPHTHALMOLOGY
    22. Boers, M
      NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection

      LANCET
    23. Hooft, L; Hoekstra, OS; Deville, W; Lips, P; Teule, GJJ; Boers, M; van Tulder, MW
      Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomographyin the follow-up of papillary or follicular thyroid cancer

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    24. Boers, M; Verhoeven, AC; van der Linden, S
      American College of Rheumatology criteria for improvement in rheumatoid arthritis should only be calculated from scores that decrease on improvement

      ARTHRITIS AND RHEUMATISM
    25. Boers, M
      Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial

      ARTHRITIS AND RHEUMATISM
    26. Boers, M; Kostense, PJ; Verhoeven, AC; van der Linden, S
      Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis

      ARTHRITIS AND RHEUMATISM
    27. Molenaar, ETM; Boers, M; Brooks, PM; Simon, L; Strand, V; Tugwell, P
      Recent developments for optimal end-points in rheumatoid arthritis clinical studies

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    28. Molenaar, E; van der Heijde, D; Boers, M
      Update on outcome assessment in rheumatic disorders

      CURRENT OPINION IN RHEUMATOLOGY
    29. Boers, M
      MRI for the early detection of sacroiliitis

      JOURNAL OF RHEUMATOLOGY
    30. Verhoeven, AC; Boers, M; van der Linden, S
      Validity of the MACTAR questionnaire as a functional index in a rheumatoidarthritis clinical trial

      JOURNAL OF RHEUMATOLOGY
    31. Verhagen, AP; de Bie, RA; Lenssen, AF; de Vet, HCW; Kessels, AGH; Boers, M; van den Brandt, PA
      Impact of quality items on study outcome - Treatments in acute lateral ankle sprains

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    32. Boers, M
      Value of magnetic resonance imaging in rheumatoid arthritis?

      LANCET
    33. Moll, AC; Imhof, SM; Schouten-van Meeteren, AYN; Boers, M
      Trilateral retinoblastoma - Is the location of the intracranial tumor important?

      CANCER
    34. Moll, AC; Imhof, SM; Schouten-Van Meeteren, AYN; Boers, M
      At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98

      BRITISH JOURNAL OF OPHTHALMOLOGY
    35. Verhoeven, AC; Boers, M; van der Linden, S
      Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis

      ANNALS OF THE RHEUMATIC DISEASES
    36. van Dieten, HEM; Korthals-de Bos, IBC; van Tulder, MW; Lems, WF; Dijkmans, BAC; Boers, M
      Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs

      ANNALS OF THE RHEUMATIC DISEASES
    37. Verhoeven, AC; Boers, M; Tugwell, P
      Combination therapy in rheumatoid arthritis

      RHEUMATOLOGY
    38. Boers, M
      The case for corticosteroids in the treatment of early rheumatoid arthritis

      RHEUMATOLOGY
    39. van der Heijde, D; Boonen, A; Boers, M; Kostense, P; van der Linden, S
      Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials

      RHEUMATOLOGY
    40. van der Heijde, D; Dankert, T; Nieman, F; Rau, R; Boers, M
      Reliability and sensitivity to change of a simplification of the Sharp/vander Heijde radiological assessment in rheumatoid arthritis

      RHEUMATOLOGY
    41. Mottonen, TT; Hannonen, PJ; Boers, M
      Combination DMARD therapy including corticosteroids in early rheumatoid arthritis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    42. Spoorenberg, A; de Vlam, K; van der Heijde, D; de Klerk, E; Dougados, M; Mielants, H; van der Tempel, H; Boers, M; van der Linden, S
      Radiological scoring methods in ankylosing spondylitis: Reliability and sensitivity to change over one year

      JOURNAL OF RHEUMATOLOGY
    43. van Gestel, AM; Anderson, JJ; van Riel, PLCM; Boers, M; Haagsma, CJ; Rich, B; Wells, G; Lange, MLM; Felson, DT
      ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials

      JOURNAL OF RHEUMATOLOGY
    44. Pham, B; Cranney, A; Boers, M; Verhoeven, AC; Wells, G; Tugwell, P
      Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials

      JOURNAL OF RHEUMATOLOGY
    45. van der Heijde, D; Boers, M; Lassere, M
      Methodological issues in radiographic scoring methods in rheumatoid arthritis

      JOURNAL OF RHEUMATOLOGY
    46. Lassere, M; Boers, M; van der Heijde, D; Boonen, A; Edmonds, J; Saudan, A; Verhoeven, AC
      Smallest detectable difference in radiological progression

      JOURNAL OF RHEUMATOLOGY
    47. Molenaar, ETH; Edmonds, J; Boers, M; van der Heijde, DMFM; Lassere, M
      A practical exercise in reading RA radiographs by the Larsen and Sharp methods

      JOURNAL OF RHEUMATOLOGY
    48. Molenaar, ETH; Boers, M; van der Heijde, DMFM; Alarcon, G; Bresnihan, B; Cardiel, M; Edmonds, J; Felson, D; Furst, DE; Kirwan, J; Lassere, M; Paulus, H; Rau, R; van Riel, PLCM; Scott, D; Simon, L; Strand, V
      Imaging in rheumatoid arthritis: Results of group discussions

      JOURNAL OF RHEUMATOLOGY
    49. Wolfe, F; Lassere, M; van der Heijde, D; Stucki, G; Suarez-Almazor, M; Pincus, T; Eberhardt, K; Kvien, TK; Symmons, D; Silman, A; van Riel, P; Tugwell, P; Boers, M
      Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology

      JOURNAL OF RHEUMATOLOGY
    50. Boers, M; Brooks, P; Strand, V; Tugwell, P
      Introduction - OMERACT IV: Fourth International Consensus Conference on Outcome Measures in Rheumatology

      JOURNAL OF RHEUMATOLOGY
    51. Gabriel, S; Tugwell, P; O'Brien, B; Yelin, E; Drummond, M; Ruff, B; Brooks, P; Bombardier, C; Boers, M
      Report of the OMERACT task force on economic evaluation

      JOURNAL OF RHEUMATOLOGY
    52. Gazarian, M; Tugwell, P; Boers, M; Bombardier, C; Brooks, P; Day, R; Strand, V; Wells, G
      Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT drug toxicity working party

      JOURNAL OF RHEUMATOLOGY
    53. Ortiz, Z; Shea, B; Dieguez, MG; Boers, M; Tugwell, P; Boonen, A; Wells, G
      The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials

      JOURNAL OF RHEUMATOLOGY
    54. Wells, G; Boers, M; Shea, B; Tugwell, P; Westhovens, R; Saurez-Almazor, M; Buchbinder, R
      Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: Preliminary findings in the generic health OMERACT study

      JOURNAL OF RHEUMATOLOGY
    55. Boers, M
      Generic measures to compare burden of disease

      NETHERLANDS JOURNAL OF MEDICINE
    56. Boers, M
      Combination therapy in rheumatoid arthritis

      LANCET
    57. VERHAGEN AP; DEVET HCW; DEBIE RA; KESSELS AGH; BOERS M; KNIPSCHILD PG
      BALNEOTHERAPY AND QUALITY ASSESSMENT - INTEROBSERVER RELIABILITY OF THE MAASTRICHT CRITERIA LIST AND THE NEED FOR BLINDED QUALITY ASSESSMENT

      Journal of clinical epidemiology
    58. Verhagen, AP; de Vet, HCW; de Bie, RA; Kessels, AGH; Boers, M; Bouter, LM; Knipschild, PG
      The delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    59. BOERS M; BROOKS P; STRAND CV; TUGWELL P
      THE OMERACT FILTER FOR OUTCOME MEASURES IN RHEUMATOLOGY

      Journal of rheumatology
    60. VERHOEVEN AC; BOERS M; TUGWELL P
      COMBINATION THERAPY IN RHEUMATOID-ARTHRITIS - UPDATED SYSTEMATIC REVIEW

      British journal of rheumatology
    61. VERHOEVEN AC; BIBO JC; BOERS M; ENGEL GL; VANDERLINDEN S
      COST-EFFECTIVENESS AND COST-UTILITY OF COMBINATION THERAPY IN EARLY RHEUMATOID-ARTHRITIS - RANDOMIZED COMPARISON OF COMBINED STEP-DOWN PREDNISOLONE, METHOTREXATE AND SULFASALAZINE WITH SULFASALAZINE ALONE

      British journal of rheumatology (Print)
    62. Giltay, EJ; Verhoeven, AC; van Schaardenburg, D; Popp-Snijders, C; Boers, M; Gooren, LJG; Dijkmans, BAC
      Serum dehydroepiandrosterone sulphate levels in patients with early rheumatoid arthritis: Positive association with C-reactive protein, but not with HLA-DR genotype

      BRITISH JOURNAL OF RHEUMATOLOGY
    63. DERE W; AVOUAC B; BOERS M; BUXTON M; CHRISTIANSEN C; DAWSON A; GENNARI C; GUILLEMIN F; LAWETZ H; ORNSKOV F; ROUMAGNAC I; REGINSTER JY
      RECOMMENDATIONS FOR THE HEALTH ECONOMICS ANALYSIS TO BE PERFORMED WITH A DRUG TO BE REGISTERED IN PREVENTION OR TREATMENT OF OSTEOPOROSIS

      Calcified tissue international
    64. BOERS M
      DOES SEX OF RHEUMATOID-ARTHRITIS PATIENTS MATTER

      Lancet
    65. BOERS M
      RANDOMIZED COMPARISON OF COMBINED STEP-DOWN PREDNISOLONE, METHOTREXATE, AND SULFASALAZINE WITH SULFASALAZINE ALONE IN EARLY RHEUMATOID-ARTHRITIS (VOL 350, PG 309, 1997)

      Lancet
    66. WOLFE F; LASERRE M; VANDERHEIDIE D; STUCKI G; SUAREZALMAZOR M; PINCUS T; EBERHARDT K; KVIEN T; SYMMONS D; SILMAN A; VANRIEL P; TUGWELL P; BOERS M
      A CORE SET OF DOMAINS FOR LONGITUDINAL OBSERVATIONAL STUDIES IN RHEUMATIC DISORDERS - CONSENSUS REPORT FROM OMERACT-4

      Arthritis and rheumatism
    67. VERHOEVEN AC; BOERS M
      LIMITED BONE LOSS DUE TO CORTICOSTEROIDS - A SYSTEMATIC REVIEW OF PROSPECTIVE STUDIES IN RHEUMATOID-ARTHRITIS AND OTHER DISEASES

      Journal of rheumatology
    68. BROOKS P; BOERS M; TUGWELL P
      OUTCOME MEASURES IN ARTHRITIS CLINICAL-TRIALS, CAIRNS, AUSTRALIA, APRIL 16-19, 1996 - INTRODUCTION - OMERACT-III - THE ACT REVISITED

      Journal of rheumatology
    69. BELLAMY N; KIRWAN J; BOERS M; BROOKS P; STRAND V; TUGWELL P; ALTMAN R; BRANDT K; DOUGADOS M; LEQUESNE M
      RECOMMENDATIONS FOR A CORE SET OF OUTCOME MEASURES FOR FUTURE PHASE-III CLINICAL-TRIALS IN KNEE, HIP, AND HAND OSTEOARTHRITIS - CONSENSUS DEVELOPMENT AT OMERACT-III

      Journal of rheumatology
    70. VERHAGEN AP; DEVET HCW; DEBIE RA; KESSELS AGH; BOERS M; KNIPSCHILD PG
      TAKING BATH - THE EFFICACY OF BALNEOTHERAPY IN PATIENTS WITH ARTHRITIS - A SYSTEMATIC REVIEW

      Journal of rheumatology
    71. BOERS M; VERHOEVEN AC; MARKUSSE HM; VANDELAAR MAFJ; WESTHOVENS R; VANDENDEREN JC; VANZEBEN D; DIJKMANS BAC; PEETERS AJ; JACOBS P; VANDENBRINK HR; SCHOUTEN HJA; VANDERHEIJDE DMFM; BOONEN A; VANDERLINDEN S
      RANDOMIZED COMPARISON OF COMBINED STEP-DOWN PREDNISOLONE, METHOTREXATE AND SULFASALAZINE WITH SULFASALAZINE ALONE IN EARLY RHEUMATOID-ARTHRITIS

      Lancet
    72. VANDERHEIJDE D; DANKERT T; NIEMAN F; RAU R; BOERS M
      RELIABILITY AND SENSITIVITY TO CHANGE OF A SIMPLIFIED SCORING METHOD FOR RADIOGRAPHS IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    73. VANDERHEIJDE D; BOONEN A; VANDERLINDEN S; BOERS M
      READING RADIOGRAPHS IN SEQUENCE, IN PAIRS OR RANDOM IN RHEUMATOID-ARTHRITIS - INFLUENCE ON SENSITIVITY TO CHANGE

      Arthritis and rheumatism
    74. BIBO JC; VERHOEVEN AC; BOERS M; VANDERLINDEN S
      COBRA COMBINATION THERAPY IS COST-EFFECTIVE IN EARLY RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    75. BOERS M; TUGWELL P; BROOKS PM
      PROGRESS TOWARDS OPTIMAL TRIAL END-POINTS IN RHEUMATOID-ARTHRITIS

      Biodrugs
    76. GOLDSMITH CH; BOERS M; BOMBARDIER C; TUGWELL PSL
      CLINICALLY IMPORTANT CHANGE IN RHEUMATOID-ARTHRITIS - REPLY

      Journal of rheumatology
    77. BOERS M; VERHOEVEN AC; MARKUSSE HM; WESTHOVENS R; VANDELAAR MAFJ; VANDENDEREN JC; VANZEBEN J; DIJKMANS BAC; PEETERS A; JACOBS P; VANDENBRINK HR; SCHOUTEN H; VANDERLINDEN S
      COMBINATION OF STEP-DOWN STEROIDS, METHOTREXATE, AND SULFASALAZINE INEARLY RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    78. VERHOEVEN AC; BOERS M; MARKUSSE HM; VANDELAAR MAFJ; WESTHOVENS R; VANDENDEREN JC; VANZEBEN J; DIJKMANS BAC; PEETERS A; JACOBS P; VANDENBRINK HR; SCHOUTEN H; BOONEN A; VANDERHEIJDE DMFM; VANDERLINDEN S
      COMBINATION OF STEP-DOWN STEROIDS, METHOTREXATE, AND SULFASALAZINE INEARLY RHEUMATOID-ARTHRITIS (COBRA) - 50-PERCENT REDUCTION IN RADIOGRAPHIC PROGRESSION COMPARED

      Arthritis and rheumatism
    79. VERHOEVEN AC; BOERS M; WOUTERS R; VANDERLINDEN S
      MINIMAL BONE LOSS IN EARLY RHEUMATOID-ARTHRITIS PATIENTS TREATED WITHSTEP-DOWN STEROID-THERAPY

      Arthritis and rheumatism
    80. VERHOEVEN A; BOERS M; VANDERLINDEN S
      COMPARISON OF THE ACR AND EULAR CRITERIA FOR PATIENT IMPROVEMENT IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    81. VERHOEVEN AC; BOERS M; VANDERLINDEN S
      COMPARISON OF SENSITIVITY TO CHANGE OF OUTCOME MEASURES IN A TRIAL ONEARLY RHEUMATOID-ARTHRITIS PATIENTS

      Arthritis and rheumatism
    82. BOERS M; VANRIEL PLCM; FELSON DT; TUGWELL P
      ASSESSING THE ACTIVITY OF RHEUMATOID-ARTHRITIS

      Bailliere's clinical rheumatology
    83. BOERS M
      THE VALIDITY OF RADIOGRAPHY AS OUTCOME MEASURE IN RHEUMATOID-ARTHRITIS

      Journal of rheumatology
    84. GOLDSMITH CH; DUKU E; BROOKS PM; BOERS M; TUGWELL PSL; BAKER P
      INTERACTIVE CONFERENCE VOTING

      Journal of rheumatology
    85. TUGWELL P; BOERS M; BROOKS P
      OMERACT-II CONFERENCE - OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - CONCLUSION

      Journal of rheumatology
    86. BOERS M; BROOKS P; TUGWELL P; BAKER P; BOMBARDIER C; DAY R; DRUMMOND M; VANDERLINDEN S; OBRIEN B; SILMAN A; STRAND V; WELLS G
      OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - ACKNOWLEDGMENTS

      Journal of rheumatology
    87. VANDERLINDEN S; BOERS M
      A FRAMEWORK TO CLASSIFY BURDEN OF ILLNESS MEASURES

      Journal of rheumatology
    88. BELLAMY N; BOERS M; FELSON D; FRIES J; FURST D; HENRY D; LIANG M; LOVELL D; MARCH L; STRAND V; VANDERLINDEN S
      WORKSHOP REPORT - HEALTH-STATUS INSTRUMENTS UTILITIES

      Journal of rheumatology
    89. BOERS M; BROOKS PM; TUGWELL P
      OMERACT - STATE OF THE ACT

      Journal of rheumatology
    90. BOERS M
      SEMINARS IN CLINICAL EPIDEMIOLOGY AND DECISION-ANALYSIS - A NEW SERIES IN THE JOURNAL

      Netherlands journal of medicine
    91. FELSON DT; ANDERSON JJ; BOERS M; BOMBARDIER C; FURST D; GOLDSMITH C; KATZ LM; LIGHTFOOT R; PAULUS H; STRAND V; TUGWELL P; WEINBLATT M; WILLIAMS HJ; WOLFE F; KIESZAK S
      AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    92. SPOORENBERG A; BOERS M; VANDERLINDEN S
      WRIST SPLINTS IN RHEUMATOID-ARTHRITIS - A QUESTION OF BELIEF

      Clinical rheumatology
    93. BOERS M; FELSON DT
      CLINICAL MEASURES IN RHEUMATOID-ARTHRITIS - WHICH ARE MOST USEFUL IN ASSESSING PATIENTS

      Journal of rheumatology
    94. HIDDING A; VANSANTEN M; DEKLERK E; GIELEN X; BOERS M; GEENEN R; VLAEYEN J; KESTER A; VANDERLINDEN S
      COMPARISON BETWEEN SELF-REPORT MEASURES AND CLINICAL OBSERVATIONS OF FUNCTIONAL DISABILITY IN ANKYLOSING-SPONDYLITIS, RHEUMATOID-ARTHRITIS AND FIBROMYALGIA

      Journal of rheumatology
    95. BOERS M; DIJKMANS BAC; BREEDVELD FC
      PREDICTION OF GLOMERULAR-FILTRATION RATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - SATISFACTORY PERFORMANCE OF COCKROFT FORMULA

      Journal of rheumatology
    96. TUGWELL P; BOERS M; BAKER P; WELLS G; SNIDER J
      END-POINTS IN RHEUMATOID-ARTHRITIS

      Journal of rheumatology
    97. BOERS M
      PREDICTING OUTCOME OF ANKYLOSING-SPONDYLITIS - PROGNOSIS OR HINDSIGHT

      Journal of rheumatology
    98. BOERS M
      DC-ART - WHAT PROPORTION OF RESPONSE CONSTITUTES A POSITIVE RESPONSE - COMMENT

      Journal of rheumatology
    99. BOERS M; TUGWELL P; FELSON DT; VANRIEL PLCM; KIRWAN JR; EDMONDS JP; SMOLEN JS; KHALTAEV N; MUIRDEN KD
      WORLD-HEALTH-ORGANIZATION AND ERNATIONAL-LEAGUE-OF-ASSOCIATIONS-FOR-RHEUMATOLOGY CORE END-POINTS FOR SYMPTOM MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS

      Journal of rheumatology
    100. FELSON D; ANDERSON J; BOERS M; BOMBARDIER C; FURST D; GOLDSMITH C; LIGHTFOOT R; PAULUS H; TUGWELL P; WEINBLATT M; KATZ L; WILLIAMS HJ; WOLFE F
      REDUCED JOINT COUNTS IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS

      Arthritis and rheumatism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 13:58:00